These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 31501577)

  • 1. The influence of the microbiome on respiratory health.
    Wypych TP; Wickramasinghe LC; Marsland BJ
    Nat Immunol; 2019 Oct; 20(10):1279-1290. PubMed ID: 31501577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-lung axis: The microbial contributions and clinical implications.
    He Y; Wen Q; Yao F; Xu D; Huang Y; Wang J
    Crit Rev Microbiol; 2017 Feb; 43(1):81-95. PubMed ID: 27781554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
    Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
    Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in the management of lung diseases.
    Mortaz E; Adcock IM; Folkerts G; Barnes PJ; Paul Vos A; Garssen J
    Mediators Inflamm; 2013; 2013():751068. PubMed ID: 23737654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lung microbiome: clinical and therapeutic implications.
    Fabbrizzi A; Amedei A; Lavorini F; Renda T; Fontana G
    Intern Emerg Med; 2019 Nov; 14(8):1241-1250. PubMed ID: 31667699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microbiota on lung homeostasis and diseases.
    Wang J; Li F; Tian Z
    Sci China Life Sci; 2017 Dec; 60(12):1407-1415. PubMed ID: 29019144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K
    Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.
    Wu BG; Segal LN
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insight into the function of the microbiome in lung diseases.
    Ubags NDJ; Marsland BJ
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lung Microbiome during Health and Disease.
    Yagi K; Huffnagle GB; Lukacs NW; Asai N
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Human Respiratory Microbiome: Implications and Impact.
    Mitchell AB; Glanville AR
    Semin Respir Crit Care Med; 2018 Apr; 39(2):199-212. PubMed ID: 29579771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-microorganism interactions in lung diseases.
    Marsland BJ; Gollwitzer ES
    Nat Rev Immunol; 2014 Dec; 14(12):827-35. PubMed ID: 25421702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives.
    Badgeley A; Anwar H; Modi K; Murphy P; Lakshmikuttyamma A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188494. PubMed ID: 33346129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
    Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
    PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Colonization Mechanisms of
    Xiao Y; Zhai Q; Zhang H; Chen W; Hill C
    Annu Rev Food Sci Technol; 2021 Mar; 12():213-233. PubMed ID: 33317320
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
    Sergeev IN; Aljutaily T; Walton G; Huarte E
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
    Shah T; Shah Z; Baloch Z; Cui X
    Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.